# PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty

> **NCT03372278** · — · ACTIVE_NOT_RECRUITING · sponsor: **Zimmer Biomet** · enrollment: 250 (actual)

## Conditions studied

- Rheumatoid Arthritis With Adequate Bone Quality
- Inflammatory Arthritis
- Osteoarthritis, Hip
- Avascular Necrosis
- Post-traumatic; Arthrosis
- Congenital Hip Dysplasia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03372278
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-01
- **Primary completion:** 2027-01
- **Final completion:** 2028-12
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03372278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03372278, "PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03372278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*